Bio Medica Laboratories shareholders and shareholding pattern
NSE: BMLLPharmaceuticals & Biotechnology
Last close ₹149.75down ₹5.25 (3.39%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹155.00.
Range of traded prices from listing on 29 May 2026 to 23 Oct 2026
₹101.50Low, 3 Jun 2026₹181.00High, 4 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹188 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 27 Jul 2026
- 16.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in May 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 27 Jul 2026
- 44.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Jul 2026
- 0.87
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 50,000100.0% delivered
Who owns Bio Medica Laboratories, filing by filing
Per cent of the company's shares. Every filing on record, from Sep 2026; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters67.70%
- Foreign institutions4.77%
- Indian institutions3.61%
- Individuals and others23.92%
| Per cent | Sep 2026Filed 17 Oct |
|---|---|
| 67.70% | |
| Indian promoters | 67.70% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 32.30% |
| Shares in issue | 1,25,75,001 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 88,03,001 |
| Promoters' shares locked in | 85,12,909 |
A dash is a line the filing did not state.
Bio Medica Laboratories promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is MUKESH MEHTA, 33.85%.
| Holder | |||
|---|---|---|---|
| MUKESH MEHTAIndividuals and Hindu undivided families | 33.85% | 42,56,316 | 100.00% |
| PRADEEP MEHTAIndividuals and Hindu undivided families | 33.85% | 42,56,225 | 100.00% |
| GARIMA MEHTAIndividuals and Hindu undivided families | 0.00% | 92 | 100.00% |
| LOKESH JAINIndividuals and Hindu undivided families | 0.00% | 92 | 100.00% |
| ANJU MEHTAIndividuals and Hindu undivided families | 0.00% | 92 | 100.00% |
| TARA MEHTAIndividuals and Hindu undivided families | 0.00% | 92 | 100.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Bio Medica Laboratories, filing by filing
Per cent, on the same shares as the split above.
| Holder | Sep 2026Filed 17 Oct |
|---|---|
| TIGER STRATEGIES FUND -IAlternative investment funds | 2.31% |
| PINE OAK GLOBAL FUNDForeign portfolio investors, category I | 2.07% |
| BASE ENGINEERING LLPCompanies | 1.59% |
| EMINENCE GLOBAL FUND PCC- EUBILIA CAPITAL PARTNERS FUND IForeign portfolio investors, category I | 1.59% |
| ALOK KUMARResident individuals, over ₹2 lakh at face value | 1.59% |
| CAPITAL TRADE LINKS LIMITEDNon-bank lenders registered with RBI | 1.30% |
| MOHAMMAD ASHRAF QURESHIResident individuals, over ₹2 lakh at face value | 1.27% |
| RATHOD MANOJ CHHAGANLAL HUFOther non-institutions | 1.07% |
| JAYANT BABULAL BOKADIAResident individuals, over ₹2 lakh at face value | 1.03% |
| DHANADEEPA CONSULTANT PRIVATE LIMITEDCompanies | 1.02% |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.